GlassScriptPhysician profile
Amir Zia
NPI 1952452583
$1,714.34
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $490 · 2021: $132.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $398.32 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $244.96 | 2019-2020 | |
| Amgen INC. | $228.71 | 2019-2020 | |
| Biogen, INC. | $216.54 | 2019-2020 | |
| Emd Serono, INC. | $215.81 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $53.28 | 2019 | |
| Allergan, INC. | $45.83 | 2020 | |
| Lundbeck LLC | $42.88 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $42.51 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $32.20 | 2019 | |
| Livanova USA, INC. | $29.94 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $24.42 | 2020 | |
| Avanir Pharmaceuticals, INC. | $20.03 | 2019 | |
| Ucb, INC. | $19.27 | 2019 | |
| Celgene Corporation | $19.23 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.07 | 2019 | |
| Abbvie INC. | $13.53 | 2020 | |
| Promius Pharma LLC | $13.11 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.03 | 2020 | |
| Lilly USA, LLC | $12.46 | 2019 | |
| Csl Behring | $12.21 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Zia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.